Streetbeat News

Marketing

AMZN

KSS

WMT

$24.5 billion of fraudulent returns during the holiday season has major retailers like Walmart and Amazon fighting back with new strategies. Walmart warns of higher prices or store closures, while Amazon spent $1.2 billion and employed 15,000 people to combat fraud using machine learning. Kohls Corp. has also adjusted its return policies to mitigate losses.

Portfolio Pulse from Caleb Naysmith

February 05, 2024 | 5:36 pm

MNMD

Elon Musk's response to a Wall Street Journal article accusing him of using illicit drugs has sparked discussions. Meanwhile, Mind Medicine Inc. (NASDAQ:MNMD), a company developing psychedelic-inspired medicines, aims to transform mental health treatment. Despite a significant drop from its 2021 highs, MindMed's research into compounds like LSD and MDMA shows promise for treating various mental health issues without traditional pharmaceuticals. The company's stock has risen 12% in the past year but remains 94% below its peak.

Portfolio Pulse from Caleb Naysmith

February 05, 2024 | 5:04 pm

AMC

LYV

RCL

Taylor Swift has filed for trademarks for 'Taylor-Con,' hinting at a potential festival for fans. The trademarks cover fan meet-ups, educational programs, and social entertainment events. This follows Swift's record-breaking 'The Eras Tour' and concert film, which saw high demand for tickets and grossed millions worldwide. Live Nation Entertainment's Ticketmaster struggled with ticket demand for Swift's tour. Additionally, fan-themed cruises organized around Swift's popularity are set for 2024, showing strong fan demand for Swift-related events.

Portfolio Pulse from Chris Katje

February 05, 2024 | 4:02 pm

OMIC

Singular Genomics Systems, Inc. (NASDAQ:OMIC) announced at the AGBT conference the unveiling of the G4X Spatial Sequencer, an upgrade to the G4 Sequencing Platform, offering high-throughput in situ spatial sequencing capabilities. The G4X is expected to be available by the end of 2024. Additionally, Singular announced updates to the G4 platform, including a higher-throughput F4 Flow Cell, improved sequencing quality, and a new web-based application for remote monitoring. The company also introduced price reductions and promotional packages for the G4 and G4X, alongside research grant programs.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 3:56 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo for February 5th, 2024, provides a trade strategy for SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA, based on a proprietary formula considering price, volume, and options flow. It offers detailed analysis for each asset, suggesting potential breakouts or reversals. The memo also highlights the importance of upcoming data releases and the Market Clubhouse community's benefits, including live trading sessions and mentorship from a pro trader known as RIPS.

Portfolio Pulse from RIPS

February 05, 2024 | 3:45 pm

AAPL

TSLA

A Tesla Inc. (TSLA) driver was pulled over for driving while wearing Apple Inc.'s (AAPL) new mixed reality headset, Apple Vision Pro. The incident has sparked a debate on social media, with some users calling for the driver's arrest for endangering road safety. The Apple Vision Pro's launch has led to various innovative and controversial uses, highlighting its potential and the risks of misuse.

Portfolio Pulse from Rounak Jain

February 05, 2024 | 1:59 pm

PROC

Procaps Group's new CEO, Jose Vieira, issued a letter to shareholders outlining his immediate focus on strengthening the company's financial position and cash management. He emphasized a commitment to transparency, innovation, and collaboration, aiming for consistent growth and profitability. Vieira plans to implement immediate actions to improve the financial situation in the short term and is developing a clear strategy for sustainable growth.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:53 pm

MGRX

Mangoceuticals, Inc. (NASDAQ:MGRX), also known as MangoRx, is launching 'PRIME', an oral testosterone replacement therapy powered by Kyzatrex. The Dallas-based telemedicine company is offering 2 months of free 'PRIME' to the first 1,000 male subscribers. This promotion is part of a broader marketing strategy, including a marquee sponsorship with Barstool Sports. PRIME is one of only three FDA-approved oral TRT treatments, promising enhanced vitality, mood, cognition, and physical performance. It will be priced at $199/month, with a 10% discount for subscribers of other MangoRx products.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:52 pm

MCD

McDonald's Corporation (NYSE:MCD) reported mixed Q4 2023 results with adjusted EPS of $2.95, beating consensus but sales of $6.41 billion fell short. U.S. same-store sales rose 4.3%, with worldwide growth at 3.4%. International sales were impacted by Middle East tensions, particularly in the developmental licensed markets segment. The company's loyalty program and digital growth contributed positively, while charges related to software write-offs and restructuring impacted operating income.

Portfolio Pulse from Vandana Singh

February 05, 2024 | 1:29 pm

TWST

Twist Bioscience Corporation (NASDAQ:TWST) announced the early access of its Twist Flex Prep Ultra High-Throughput (UHT) Kit, designed to significantly reduce costs and increase efficiency in NGS workflows, particularly in agricultural genomics. The kit features novel Normalization By Ligation (NBL) technology for self-normalizing sample inputs, enhanced multiplexing capabilities, and compatibility with automation systems. This innovation is expected to accelerate NGS adoption in AgBio by offering a scalable, streamlined, and cost-effective solution. Twist Bioscience will showcase this technology at the AGBT General Meeting in Orlando, FL.

Portfolio Pulse from Benzinga Newsdesk

February 05, 2024 | 1:24 pm